X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs SUVEN LIFE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA SUVEN LIFE PLETHICO PHARMA/
SUVEN LIFE
 
P/E (TTM) x -1.1 16.6 - View Chart
P/BV x 0.0 3.1 0.5% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 PLETHICO PHARMA   SUVEN LIFE
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
SUVEN LIFE
Mar-16
PLETHICO PHARMA/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs395339 116.7%   
Low Rs31144 21.7%   
Sales per share (Unadj.) Rs604.439.2 1,540.0%  
Earnings per share (Unadj.) Rs32.57.5 435.3%  
Cash flow per share (Unadj.) Rs51.38.8 584.9%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs473.649.0 966.5%  
Shares outstanding (eoy) m34.08127.28 26.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.46.2 5.7%   
Avg P/E ratio x6.632.4 20.3%  
P/CF ratio (eoy) x4.227.5 15.1%  
Price / Book Value ratio x0.54.9 9.1%  
Dividend payout %026.8 0.0%   
Avg Mkt Cap Rs m7,26230,732 23.6%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m1,596416 383.3%   
Avg. sales/employee Rs ThNM5,236.1-  
Avg. wages/employee Rs ThNM436.5-  
Avg. net profit/employee Rs ThNM995.5-  
INCOME DATA
Net Sales Rs m20,5984,995 412.4%  
Other income Rs m386194 199.7%   
Total revenues Rs m20,9845,189 404.4%   
Gross profit Rs m2,8181,233 228.6%  
Depreciation Rs m642167 384.2%   
Interest Rs m1,59354 2,939.5%   
Profit before tax Rs m9691,205 80.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138255 -54.3%   
Profit after tax Rs m1,107950 116.6%  
Gross profit margin %13.724.7 55.4%  
Effective tax rate %-14.321.2 -67.5%   
Net profit margin %5.419.0 28.3%  
BALANCE SHEET DATA
Current assets Rs m18,8774,986 378.6%   
Current liabilities Rs m11,8961,042 1,141.4%   
Net working cap to sales %33.979.0 42.9%  
Current ratio x1.64.8 33.2%  
Inventory Days Days3661 58.9%  
Debtors Days Days19839 505.5%  
Net fixed assets Rs m9,8613,126 315.5%   
Share capital Rs m341127 267.6%   
"Free" reserves Rs m12,3313,717 331.7%   
Net worth Rs m16,1396,236 258.8%   
Long term debt Rs m4,706432 1,088.5%   
Total assets Rs m33,1468,079 410.3%  
Interest coverage x1.623.2 6.9%   
Debt to equity ratio x0.30.1 420.6%  
Sales to assets ratio x0.60.6 100.5%   
Return on assets %8.112.4 65.6%  
Return on equity %6.915.2 45.0%  
Return on capital %12.318.9 65.1%  
Exports to sales %21.487.5 24.4%   
Imports to sales %15.212.2 124.5%   
Exports (fob) Rs m4,4024,371 100.7%   
Imports (cif) Rs m3,136611 513.4%   
Fx inflow Rs m4,4024,666 94.3%   
Fx outflow Rs m3,184942 338.0%   
Net fx Rs m1,2193,724 32.7%   
CASH FLOW
From Operations Rs m2,437922 264.4%  
From Investments Rs m-6,265-619 1,011.6%  
From Financial Activity Rs m2,490-698 -356.5%  
Net Cashflow Rs m-1,337-396 337.9%  

Share Holding

Indian Promoters % 82.7 63.4 130.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 0.0 -  
FIIs % 5.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 36.5 20.5%  
Shareholders   10,665 37,287 28.6%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  WOCKHARDT LTD.  

Compare PLETHICO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 5-YR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS